|
|
AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill., Feb. 18, 2016 -- The board of directors of AbbVie Inc.
(NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.
The cash dividend is payable May 16, 2016 to stockholders of record at the close
of business on April 15, 2016.
Since the company's inception in 2013, AbbVie has increased its dividend by more
than 42... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Reports FullYear 2015 and FourthQuarter Financial Results
Reports FullYear Adjusted EPS of $4.29, Up 29.2 Percent; GAAP EPS of $3.13
Delivers FullYear Adjusted Net Revenues of $22.819 Billion, Up 22.1 Percent on an Operational Basis;
GAAP Net Revenues of $22.859 Billion, Up 14.5 Percent
Expanded Adjusted Operating Margin to 42.3 Percent in 2015, Up 610 Basis Points; Adjusted... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Reports ThirdQuarter 2015 Financial Results
Reports ThirdQuarter Adjusted EPS of $1.13, Up Nearly 27 Percent and Exceeding Previous
Guidance Range of $1.04 to $1.06; Reports GAAP EPS of $0.74
Delivers ThirdQuarter Revenue of $5.944 Billion, an Increase of 26.2 Percent Over ThirdQuarter
2014 on an Operational Basis Excluding 7.8 Percent Unfavorable Exchange; Reported... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Outlines Long-Term Strategic and Financial Objectives; Company
Positioned for Strong Performance
- Company Expects to Deliver Double-Digit Adjusted Earnings-Per-Share (EPS)
Growth on Average Through 2020
- Guides to Total Company Sales of Approximately $37 Billion in 2020
- Targeting 2020 Global HUMIRA Sales of More Than $18 Billion and IMBRUVICA
Revenue of Approximately $5... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Illinois, Sept. 11, 2015 -- The board of directors of AbbVie Inc.
(NYSE: ABBV) declared a quarterly cash dividend of $0.51 per share.
The cash dividend is payable Nov. 14, 2015 to stockholders of record at the
close of business on Oct. 15, 2015.
About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Reports SecondQuarter 2015 Financial Results
Reports SecondQuarter Adjusted EPS of $1.08, Up 31.7 Percent and Exceeding Previous Guidance
Range of $1.04 to $1.06 Reports GAAP EPS of $0.83
Delivers SecondQuarter Revenue of $5.475 Billion, an Increase of 19.4 Percent Over Second
Quarter 2014 on an Operational Basis Excluding 8.3 Percent Unfavorable Exchange. Reported... Lire le communiqué |
|
| |
|
| |
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
AMENDMENT NO. 10
RULE 14D100
... Lire le communiqué |
|
| |
|
| |
